CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Pharma
Original article

Memorial Cancer Institute among first in South Florida to acquire breakthrough drug to treat pancreatic cancer

RegulatoryapproveddaraxonrasibPositive
AI Analysis

Summary

Memorial Cancer Institute became the first cancer program in Broward County, Florida to obtain daraxonrasib, a breakthrough drug for pancreatic cancer treatment. The acquisition represents a significant development in pancreatic cancer therapy.

Outcome Details

Drug acquisition by Memorial Cancer Institute, described as breakthrough treatment for pancreatic cancer

Importance:3/10
Sentiment:
0.70
pancreatic cancerbreakthrough treatmentdrug acquisitiononcologySouth Florida
Related Companies
$TRAX

Read the original article

Published by PR Newswire Pharma on August 31, 2026 5:04 PM

Read Original